Research study Program year 2022 Source: CMS Open Payments

Lex-209

Research payments

$51,730

57 payments

Through program year 2022, $51,730 in research payments was reported against Lex-209, across 57 payments, paid by Octapharma USA, Inc..

Paid by: Octapharma USA, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$19,099	15
2021	Research	$32,631	42

Breakdown

Who paid Research payments · program years 2021–2022

Octapharma USA, Inc. $51,730 57 payments

Who received the money Research payments · program years 2021–2022

Yale University Organisation paid for research $8,956 2 payments
Ravindra Sarode Blood Banking & Transfusion Medicine · Dallas, TX $7,700 2 payments
Frank Sellke Thoracic Surgery (Cardiothoracic Vascular Surgery) · Providence, RI $7,666 11 payments
Melissa Cushing Clinical Pathology/Laboratory Medicine · New York, NY $5,483 12 payments
Truman Milling Emergency Medicine · Austin, TX $4,911 1 payment
Kenichi Tanaka Anesthesiology · Oklahoma City, OK $4,498 10 payments
Gregory Simonian Vascular Surgery · Hackensack, NJ $4,000 1 payment
Berry Consultants Organisation paid for research $3,910 4 payments
Michael Cripps Surgery · Aurora, CO $2,550 10 payments
Roger Lewis Emergency Medicine · Torrance, CA $989 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

3 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.